While allelic matching at HLA-A, -B, -C, and -DRB1 is considered the standard for unrelated HCT, increasing evidence suggests that matching at DPB1 and DRB3/4/5 loci also impacts transplant survival and GVHD risk. The gene discussed is HLA-A; the disease is graft versus host disease.